| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/02/2004 | CN1151828C Medicine for treating bone fracture and preparation method |
| 06/02/2004 | CN1151822C Liquid medicine for treating traumatic injury |
| 06/02/2004 | CN1151817C Fracture setting granule for treating bone injury and its preparation process |
| 06/02/2004 | CN1151816C Fracture setting capsule of traditional Chinese medicine for treating bone injury and its preparation process |
| 06/02/2004 | CN1151814C Traditonal Chinese medicine composition for treating rheumatic syndrome |
| 06/02/2004 | CN1151793C Medicinal composition for treating osseous lesion in multiple myeloma |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743815 Estrogen receptor modulators |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743805 Treating vascular proliferative disorders |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743774 Tribonectins |
| 06/01/2004 | US6743607 Production of complex carbohydrates |
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 06/01/2004 | US6743414 Bone disorders; osteoporosis |
| 06/01/2004 | CA2118219C Preparations of low molecular weight hyaluronic acid for stimulating bone formation |
| 05/27/2004 | WO2004043959A1 Novel parp inhibitors |
| 05/27/2004 | WO2004043956A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | WO2004043912A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/27/2004 | WO2004043491A1 Remedies for vertebral canal stenosis |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004043367A2 Fused heterocyclic compounds and use thereof |
| 05/27/2004 | WO2004016583A8 Substituted glycine derivatives for use as medicaments |
| 05/27/2004 | WO2003099992A3 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | WO2002057284A8 New inhibitors against galectins |
| 05/27/2004 | WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102524 Method of treatment |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102498 Estrogen receptor modulators |
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102365 Pharmaceutical composition for prevention and remedy of osteoporosis |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | CA2505876A1 Novel parp inhibitors |
| 05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | CA2505365A1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/27/2004 | CA2503995A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 05/26/2004 | EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421934A1 Remedial agent for arthrosis deformans |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421118A1 A method for the treatment or prevention of bone erosion |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421067A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420827A1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 05/26/2004 | EP1420824A2 Compound |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420801A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420792A2 Products and drug delivery vehicles |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420771A2 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1206474B1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/26/2004 | EP1149057B1 Biodegradable glass compositions and their use in the manufacture of a medicament for radiation therapy |
| 05/26/2004 | EP1123110A4 Compositions and methods for promoting tissue repair using heat shock proteins |
| 05/26/2004 | EP1098873B1 Alpha-(2-hydroxyphenyl)nitrone compounds, pharmaceutical compositons containing the same and their use for treating inflammation |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499983A Remedies for infact chronic arthritis-relating diseases |